Healix (503B Compounding Pharmacy Services Division) Overview

  • Status
  • Acquired/​Merged
  • Latest Deal Type
  • Buyout/​LBO
  • Financing Rounds
  • 1

Healix (503B Compounding Pharmacy Services Division) General Information

Description

Provider of compounded sterile preparation services. The company provides high-quality, ready-to-use compounded sterile preparations to hospitals across the country through its manufacturing facility that is registered with the U.S. Food and Drug Administration (FDA) as an Outsourcing Facility under Section 503B of the Federal Food, Drug, and Cosmetic Act.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Private Equity-Backed
Primary Industry
Pharmaceuticals
Acquirer
QuVa Pharma
Primary Office
  • 14140 Southwest Freeway
  • Suite 400
  • Sugar Land, TX 77478
  • United States
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Healix (503B Compounding Pharmacy Services Division) Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA		 Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Healix (503B Compounding Pharmacy Services Division)‘s full profile, request access.

Request a free trial

Healix (503B Compounding Pharmacy Services Division) Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Healix (503B Compounding Pharmacy Services Division)‘s full profile, request access.

Request a free trial